Clinical Trial 55077

Morgantown, WV 26505


The primary efficacy objective for this study is to evaluate the efficacy of a single,
oral dose of BXM compared with placebo to prevent secondary within-household
transmission of influenza A/B.


IP's must be between 5 and 64 years old 

Test positive for influenza and have influenza symptom onset within 48 hours. 

Not at high risk for complications of influenza. 

Ip's must live with 1 or more HHC's that have been unvaccinated for influenza within the last 6 months.  



Qualified Participants May Receive:

Up to $525.

Available At:

Frontier Clinical Research
1526 Mileground Rd, Ste. A
Morgantown, WV 26505
View Clinic Location


If you or someone you care for is interested in participating and lives within 50 miles of the location shown, please complete the form below and click 'Submit'

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.